Search Result "NAFLD-HCC."
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5239-5249
Author(s): Samuele De Minicis, Chris Day, Gianluca Svegliati-Baroni
Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 32 Year: 2020 Page: 3909-3914
Author(s): Francesco Tovoli,Silvia Ferri,Fabio Piscaglia
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Ebook: Nonalcoholic Fatty Liver Disease (NAFLD)
Volume: 1 Year: 2017
Author(s): György Baffy
Doi: 10.2174/9781681084657117010011
Circulating MicroRNAs: Diagnostic Value as Biomarkers in the Detectionof Non-alcoholic Fatty Liver Diseases and Hepatocellular Carcinoma
Journal: MicroRNA
Volume: 12 Issue: 2 Year: 2023 Page: 99-113
Author(s): Dinesh Kumar Mehta
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: From a Clinical to a Molecular Association
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 6 Year: 2010 Page: 741-752
Author(s): S. Petta, A. Craxi
NAFLD: Diagnostic Algorithms for Regulating Patient Fluxes
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 27 Year: 2021 Page: 3036-3046
Author(s): Giada Pallini,Emmanuel A. Tsochatzis
The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 32 Year: 2020 Page: 3928-3938
Author(s): Grazia Pennisi,Ciro Celsa,Antonina Giammanco,Federica Spatola,Salvatore Petta
Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib
Journal: Current Drug Targets
Volume: 17 Issue: 7 Year: 2016 Page: 783-799
Author(s): Gianluigi Mazzoccoli,Luca Miele,Jude Oben,Antonio Grieco,Manlio Vinciguerra
Weighted Gene Co-Expression Network Analysis of Immune Infiltration inNonalcoholic Fatty Liver Disease
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 9 Year: 2023 Page: 1173-1185
Author(s):
Current and Future Therapeutic Strategies in NAFLD
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 1958-1962
Author(s): Nimantha Mark Wilfred de Alwis, Christopher Paul Day